In vitro inhibition of mitochondrial respiratory rate by antidepressants

被引:70
作者
Hroudova, Jana
Fisar, Zdenek [1 ]
机构
[1] Charles Univ Prague, Dept Psychiat, Fac Med 1, Prague 12000, Czech Republic
关键词
Antidepressant; Mood stabilizer; Mitochondria; Respiratory rate; OXIDATIVE-PHOSPHORYLATION; BRAIN; DRUG; DYSFUNCTION; FLUOXETINE; VALPROATE; STRESS; NEUROLEPTICS; IMIPRAMINE; PROTECTION;
D O I
10.1016/j.toxlet.2012.07.017
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Mitochondria represent a possible drug target with unexplored therapeutic and toxicological potential. The possibility was suggested that antidepressants, mood stabilizers and other drugs may show some therapeutic and/or toxic effects through their action on mitochondrial functions. There are no sufficient data about the effect of these drugs on mitochondrial respiration in the brain. We investigated the in vitro effects of amitriptyline, fluoxetine, tianeptine, ketamine, lithium, valproate, olanzapine, chlorpromazine and propranolol on mitochondrial respiration in crude mitochondrial fractions of pig brains. Respiration was energized using substrates of complex I or complex II and dose dependent drug-induced changes in mitochondrial respiratory rate were measured by high-resolution respirometry. Antidepressants, but not mood stabilizers, ketamine and propranolol were found to inhibit mitochondrial respiratory rate. The effective dose of antidepressants reaching half the maximal respiratory rate was in the range of 0.07-0.46 mmol/L. Partial inhibition was found for all inhibitors. Differences between individual drugs with similar physicochemical properties indicate selectivity of drug-induced changes in mitochondrial respiratory rate. Our findings suggest that mood stabilizers do not interfere with brain mitochondrial respiration, whereas direct mitochondrial targeting is involved in mechanisms of action of pharmacologically different antidepressants. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:345 / 352
页数:8
相关论文
共 62 条
[31]  
KARSON CN, 1993, J NEUROPSYCH CLIN N, V5, P322
[32]   Mitochondrial dysfunction in bipolar disorder [J].
Kato, T ;
Kato, N .
BIPOLAR DISORDERS, 2000, 2 (03) :180-190
[33]   ALTERED ENERGY COUPLING IN RAT-HEART MITOCHONDRIA FOLLOWING INVIVO TREATMENT WITH PROPRANOLOL [J].
KATYARE, SS ;
RAJAN, RR .
BIOCHEMICAL PHARMACOLOGY, 1991, 42 (03) :617-623
[34]   Mitochondrial defects and heterogeneous cytochrome c release after cardiac cold ischemia and reperfusion [J].
Kuznetsov, AV ;
Schneeberger, S ;
Seiler, R ;
Brandacher, G ;
Mark, W ;
Steurer, W ;
Saks, V ;
Usson, Y ;
Margreiter, R ;
Gnaiger, E .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2004, 286 (05) :H1633-H1641
[35]   Psychopharmacological Neuroprotection in Neurodegenerative Disease: Assessing the Preclinical Data [J].
Lauterbach, Edward C. ;
Victoroff, Jeff ;
Coburn, Kerry L. ;
Shillcutt, Samuel D. ;
Doonan, Suzanne M. ;
Mendez, Mario F. .
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2010, 22 (01) :8-18
[36]   Brain mitochondrial nitric oxide synthase: in vitro and in vivo inhibition by chlorpromazine [J].
Lores-Arnaiz, S ;
D'Amico, G ;
Czerniczyniec, A ;
Bustamante, J ;
Boveris, A .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2004, 430 (02) :170-177
[37]  
LOWRY OH, 1951, J BIOL CHEM, V193, P265
[38]   Inhibition of complex I by neuroleptics in normal human brain cortex parallels the extrapyramidal toxicity of neuroleptics [J].
Maurer, I ;
Moller, HJ .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 1997, 174 (1-2) :255-259
[39]   Lithium-induced enhancement of mitochondrial oxidative phosphorylation in human brain tissue [J].
Maurer, Iris C. ;
Schippel, Patricia ;
Volz, Hans-Peter .
BIPOLAR DISORDERS, 2009, 11 (05) :515-522
[40]   The neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation [J].
McEwen, B. S. ;
Chattarji, S. ;
Diamond, D. M. ;
Jay, T. M. ;
Reagan, L. P. ;
Svenningsson, P. ;
Fuchs, E. .
MOLECULAR PSYCHIATRY, 2010, 15 (03) :237-249